date:Jun 08, 2015
m from H. Lee, Chemistry Review Group, Division of Petition Review, to E. Anderson, Regulatory Group II, Division of Petition Review, March 13, 2015.
3. FDA Memorandum from S. Park, Toxicology Team, Division of Petition Review, to E. Anderson, Regulatory Group II, Division of Petition Review, March 18, 2015.
List of Subjects in21 CFR Part 73
Color additives
Cosmetics
Drugs
Medical devices
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority